The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis

被引：19

作者：

Carol, Emily E. ^{[1
]}

Spencer, Robert L. ^{[1
]}

Mittal, Vijay A. ^{[2
]}

机构：

[1] Univ Colorado, Dept Psychol & Neurosci, Ctr Neurosci, Boulder, CO 80309 USA

[2] Northwestern Univ, Dept Psychol, Dept Psychiat, Inst Policy Res,Dept Medial Social Sci, Evanston, IL 60208 USA

来源：

PSYCHONEUROENDOCRINOLOGY | 2017年 / 83卷

基金：

美国国家卫生研究院;

关键词：

Cortisol; Cannabis; HPA axis; Prodrome; High-Risk; Schizophrenia; CLINICAL HIGH-RISK; PITUITARY-ADRENAL AXIS; MINOR PHYSICAL ANOMALIES; SUBSTANCE USE DISORDERS; AWAKENING RESPONSE; STRESS-RESPONSE; SEX-DIFFERENCES; INDIVIDUALS; ADOLESCENTS; SCHIZOPHRENIA;

D O I：

10.1016/j.psyneuen.2017.04.017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recent studies have posited a relationship between cannabis use and the biological stress system, but this critical relationship has not been evaluated during the ultra high-risk (UHR) period immediately preceding the onset of psychotic disorders. Salivary cortisol samples were collected on 46 UHR and 29 control adolescents; these individuals were assessed for current cannabis use with a urine panel and self-report. UHR participants where separated into two groups: Current Cannabis Use (UHR-CU) and No Current Cannabis Use (UHR-NC). Healthy Control participants (HC) were free of cannabis use. Consistent with the literature, results indicate UHR individuals showed elevated cortisol levels when compared to HC participants. Further, we also observed that UHR-CU participants exhibited elevated levels when compared to both the non-using UHR and HC groups. Findings suggest that cannabis use may interact with underlying biological vulnerability associated with the hypothalamic-pituitary-adrenal (HPA) axis system.

引用

页码：58 / 64

页数：7

共 60 条

[1] Substance use in clinical high risk for psychosis: a review of the literature
Addington, Jean
Case, Nevicia
Saleem, Majid M.
Auther, Andrea M.
Cornblatt, Barbara A.
Cadenhead, Kristin S.
[J]. EARLY INTERVENTION IN PSYCHIATRY, 2014, 8 (02) : 104 - 112
[2] Stress abnormalities in individuals at risk for psychosis: A review of studies in subjects with familial risk or with "at risk" mental state
Aiello, Giuliano
Horowitz, Mark
Hepgul, Nilay
Pariante, Carmine M.
Mondelli, Valeria
[J]. PSYCHONEUROENDOCRINOLOGY, 2012, 37 (10) : 1600 - 1613
[3] [Anonymous], 1996, OUTCOMES ASSESSMENT
[4] [Anonymous], 1996, BDI 2 BECK DEPRESSIO
[5] Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids
Appiah-Kusi, E.
Leyden, E.
Parmar, S.
Mondelli, V.
McGuire, P.
Bhattacharyya, S.
[J]. PSYCHOLOGICAL MEDICINE, 2016, 46 (01) : 27 - 45
[6] Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome
Auther, A. M.
McLaughlin, D.
Carrion, R. E.
Nagachandran, P.
Correll, C. U.
Cornblatt, B. A.
[J]. PSYCHOLOGICAL MEDICINE, 2012, 42 (12) : 2485 - 2497
[7] Endocrine effects of marijuana
Brown, TT
Dobs, AS
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11) : 90S - 96S
[8] Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders
Brunette, Mary F.
Drake, Robert E.
Xie, Haiyi
McHugo, Gregory J.
Green, Alan I.
[J]. SCHIZOPHRENIA BULLETIN, 2006, 32 (04) : 637 - 643
[9] Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing
Buchan, BJ
Dennis, ML
Tims, FM
Diamond, GS
[J]. ADDICTION, 2002, 97 : 98 - 108
[10] Substance use in individuals at clinical high risk of psychosis
Buchy, L.
Cadenhead, K. S.
Cannon, T. D.
Cornblatt, B. A.
McGlashan, T. H.
Perkins, D. O.
Seidman, L. J.
Tsuang, M. T.
Walker, E. F.
Woods, S. W.
Heinssen, R.
Bearden, C. E.
Mathalon, D.
Addington, J.
[J]. PSYCHOLOGICAL MEDICINE, 2015, 45 (11) : 2275 - 2284

← 1 2 3 4 5 6 →